InnoCore Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.57M

  • Investors
  • 1

InnoCore Pharmaceuticals General Information

Description

Developer of long-acting injectable drug delivery formulations designed to help the treatment of chronic diseases. The company utilizes its proprietary drug delivery technology to develop biodegradable sustained-release depots for precisely controlled delivery of therapeutic compounds, enabling doctors to provide optimal treatment that improves the quality of life of patients.

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • L.J. Zielstraweg 1
  • 9713 GX Groningen
  • Netherlands
+31 050
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • L.J. Zielstraweg 1
  • 9713 GX Groningen
  • Netherlands
+31 050

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InnoCore Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 01-Jun-2020 $1.57M Completed Generating Revenue
To view InnoCore Pharmaceuticals’s complete valuation and funding history, request access »

InnoCore Pharmaceuticals Patents

InnoCore Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3180971-A1 Long-acting bupivacaine microsphere formulations Pending 22-Apr-2020
JP-2024091835-A Long-acting bupivacaine microsphere formulations Pending 22-Apr-2020
US-20240033221-A1 Long-acting bupivacaine microsphere formulations Pending 22-Apr-2020
WO-2021216928-A1 Long-acting bupivacaine microsphere formulations Inactive 22-Apr-2020
CA-3179866-A1 Long-acting apomorphine formulations and injectors for therapeutic delivery of the same Pending 10-Apr-2020 A61K31/485
To view InnoCore Pharmaceuticals’s complete patent history, request access »

InnoCore Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnoCore Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gates Foundation Not-For-Profit Venture Capital
To view InnoCore Pharmaceuticals’s complete investors history, request access »

InnoCore Pharmaceuticals Investments & Acquisitions (2)

InnoCore Pharmaceuticals’s most recent deal was a Merger/Acquisition with InGell. The deal was made on 01-Dec-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
InGell 01-Dec-2017 Merger/Acquisition Drug Delivery
InGell 01-Jan-2015 Corporate Drug Delivery
To view InnoCore Pharmaceuticals’s complete investments and acquisitions history, request access »

InnoCore Pharmaceuticals FAQs

  • When was InnoCore Pharmaceuticals founded?

    InnoCore Pharmaceuticals was founded in 2004.

  • Where is InnoCore Pharmaceuticals headquartered?

    InnoCore Pharmaceuticals is headquartered in Groningen, Netherlands.

  • What is the size of InnoCore Pharmaceuticals?

    InnoCore Pharmaceuticals has 48 total employees.

  • What industry is InnoCore Pharmaceuticals in?

    InnoCore Pharmaceuticals’s primary industry is Drug Delivery.

  • Is InnoCore Pharmaceuticals a private or public company?

    InnoCore Pharmaceuticals is a Private company.

  • What is InnoCore Pharmaceuticals’s current revenue?

    The current revenue for InnoCore Pharmaceuticals is .

  • Who are InnoCore Pharmaceuticals’s investors?

    Gates Foundation has invested in InnoCore Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process